It has been revealed that in cancer cells, cardiac glycosides induce apoptosis by down-regulating the anti-apoptotic proteins Bcl-XL and Bcl-2 as well as Mcl-1 and increasing the pro-apoptotic proteins Bid and Bax57,58,86–89. Here, BCL2L1 is linked to cancer.